Quick Takeaways
- NORTHSTRIVE FUND II LP filed SCHEDULE 13D for Bluejay Diagnostics, Inc. Common Stock, par value $0.0001 per share (BJDX).
- Disclosed ownership: 3.6%.
- Date of event: 11 Mar 2026.
NORTHSTRIVE FUND II LP - 11 Mar 2026 SCHEDULE 13D Report for Bluejay Diagnostics, Inc. Common Stock, par value $0.0001 per share (BJDX)
- Filing Manager
- NORTHSTRIVE FUND II LP
- Reporting Manager
- Braeden Lichti
- Symbol
- BJDX
- Shares outstanding
- 972,603 shares
- Disclosed Ownership
- 35,500 shares
- Ownership
- 3.6%
- Form type
- SCHEDULE 13D
- Filing time
- 11 Mar 2026, 08:12:54 UTC
- Date of event
- 11 Mar 2026
- Previous filing
- 05 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"NORTHSTRIVE FUND II LP disclosed 3.6% ownership in Bluejay Diagnostics, Inc. Common Stock, par value $0.0001 per share (BJDX) on 11 Mar 2026."
What Changed
- Previous schedule filing date: 05 Feb 2026.
- Current filing was accepted on 11 Mar 2026, 08:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Braeden Lichti | 3.6% | 35,500 | 24,500 | 11,000 | /s/ Braeden Lichti | Braeden Lichti | 0001982476 |
| Northstrive Fund II LP | 1.1% | 11,000 | 0 | 11,000 | /s/ Braeden Lichti | Braeden Lichti/Manager | 0002099270 |